Myopia (nearsightedness) is growing faster than ever — and childhood is the best time to intervene. Our evidence-based treatments are designed to slow progression and protect your child's long-term vision health.
Myopia isn't just about needing thicker glasses — high myopia is associated with significantly increased risks for retinal detachment, glaucoma, and other serious eye conditions later in life. Myopia control slows the rate of progression during the critical years when the eye is still growing, reducing your child's lifetime risk.
Myopia control is most effective during the years when the eye is still growing — typically between ages 6 and 16. If your child is already myopic, now is the time to act.
Children with worsening prescriptions
If your child's prescription has increased significantly year over year, myopia control treatment can help slow that progression before it reaches a high level.
Children with myopic parents
Myopia has a strong genetic component. If one or both parents are nearsighted, their children are at significantly higher risk — making early evaluation and intervention especially important.
Parents seeking proactive protection
Even children with mild myopia benefit from early treatment. Starting control therapy sooner means fewer diopters gained over the long run — and a lower lifetime risk of complications.
There is no one-size-fits-all approach to myopia control. We evaluate your child's age, prescription, lifestyle, and rate of progression to recommend the best-fit treatment — then monitor their response over time.
Specially designed spectacle lenses that help slow the progression of myopia in children by reducing eye strain during growth — providing clear vision while helping protect long-term eye health.
Specialty daytime soft lenses with a peripheral defocus design that reduces the stimulus driving myopia growth — a comfortable option for active kids.
A nightly eye drop at very low concentration has been shown in clinical studies to significantly slow myopia progression with minimal side effects. Often used alongside optical correction.
Still have questions? Our team is glad to walk you through your child's options in detail.
Clinical studies show that myopia control treatments — including orthokeratology, multifocal contact lenses, and low-dose atropine — can slow myopia progression by 40–60% on average compared to standard glasses or contact lenses. Results vary by individual, and regular monitoring helps us optimize treatment over time.
Most myopia control treatments are suitable for children as young as 6–8 years old, depending on the specific therapy. The earlier treatment begins, the greater the cumulative benefit — since myopia progresses most rapidly during childhood and adolescence.
No — myopia control does not reverse or eliminate existing nearsightedness. Its goal is to slow the rate of progression, so that your child ends up with a lower prescription than they otherwise would have. This reduces their risk of high myopia and its associated complications later in life.
Coverage for myopia control treatments varies widely by insurance plan. Some plans cover specialty contact lens fittings or atropine prescriptions; others do not. We recommend checking with your insurance provider and discussing options with our team — we can help you understand what to expect and explore cost-effective treatment paths.
Most myopia control patients are seen every 6 months for a progress exam and prescription check. More frequent visits may be needed at the start of treatment or if we need to adjust the approach. We track progression at each visit to evaluate how well the treatment is working.
Schedule a myopia control consultation — our team will help you find the right approach for your child.